BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2004
View Archived Issues
S-21403 reported to reduce the effects of postprandial hyperglycemia in type 2 diabetes
Read More
Four series of PPAR modulators reported by Lilly
Read More
Novel CGRP antagonists for migraine therapy presented by Boehringer Ingelheim
Read More
Novel HIV integrase inhibitors in early development at BMS
Read More
Merck researchers develop new macrocyclic BACE inhibitors
Read More
New porphyrin derivatives and their use in cancer radiotherapy
Read More
New antitumor conjugates with improved half-life designed at Bracco
Read More
Cambridge Laboratories acquires U.K. rights to palonosetron
Read More
Sirna Therapeutics files IND to advance Sirna-027 into clinic
Read More
Mylan and King proceed with acquisition plans
Read More
Series B financing at MAP Pharmaceuticals to advance inhaled drug products
Read More
Vertex completes dosing in phase Ia study of VX-950 for HCV
Read More
Sunesis and Biogen Idec collaborate on small molecule oncology products
Read More
VaxGen cleared to begin clinical testing of smallpox vaccine LC16m8
Read More
Taisho and Arena identify potent MCH receptor antagonist ATC-0065
Read More
Novel small molecule VLA-4 antagonist for asthma reported by Uriach
Read More
Serono highlights second quarter developments
Read More
Crucell updates PER.C6 development
Read More
Schering-Plough reviews recent significant developments
Read More
First phase II Oxycyte protocol submitted
Read More
Good patient satisfaction achieved with Respimat SMI in the management of COPD
Read More
Clinical evidence suggests that TH-9507 improves functional performance of COPD patients
Read More
Treatment commences in West Nile study of Alferon N
Read More
Therapeutic benefits of the PPAR agonist muraglitazar in diabetes
Read More
Takara Bio and CAMS to codevelop cancer immunotherapies in China
Read More
ZymoGenetics and Serono establish broad alliance
Read More
Crucell signs PER.C6 license agreement with MorphoSys
Read More
Vioxx approved for once-daily treatment of juvenile rheumatoid arthritis
Read More
MB-06322 demonstrates activity in preclinical models of diabetes
Read More
Activity of BLX-1002 assessed in vitro, in vivo
Read More
Novel, selective chemokine CXCR2 receptor antagonist SB-656933 inhibits neutrophil CD11b expression
Read More